References
- Barsoum SC, Milgram W, Mackay W, Coblentz C, Delaney KH, Kwiecien JM, et al. 2003. Delivery of recombinant gene product to canine brain with the use of microencapsulation. J Lab Clin Med. 142:399–413.
- Basic D, Vacek I, Sun AM. 1996. Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy. Artif Cells Blood Substit Immobil Biotechnol. 24:219–255.
- Chang TM. 1964. Semipermeable microcapsules. Science. 146:524–525.
- Cruz L, Assumpcao E, Andrade SF, Conrado DJ, Guterres SS, Pohlmann AR. 2010. Microencapsulation of sodium alendronate reduces drug mucosal damage in rats. Drug Deliv. 17:231–237.
- Fan J, Park H, Tan S, Lee M. 2013. Enhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2. PLoS One. 8:e72474.
- Freundlieb S, Schirra-Muller C, Bujard H. 1999. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med. 1:4–12.
- Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, et al. 2004. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther. 9:587–595.
- Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 89:5547–5551.
- Han Q, Zhang B, Chen B, Dai J, Xu J, Wang C, Wang Z. 2013. Evaluation of a bioactive bone-inducing material consisting of collagen scaffolds and collagen-binding BMP2. J Biomed Mater Res A.
- Hernandez-Valdepena I, Braud C, Coudane J, Domurado D, Vert M. 2005. Molecular microencapsulation for in vivo transport of water-insoluble drugs. J Control Release. 101:296–297.
- Hidaka C, Goshi K, Rawlins B, Boachie-Adjei O, Crystal RG. 2003. Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine (Phila Pa 1976). 28:2049–2057.
- Hortelano G. 2010. Therapeutic applications of cell microencapsulation. Foreword. Adv Exp Med Biol. 670:vii–viii.
- Khaled EG, Saleh M, Hindocha S, Griffin M, Khan WS. 2011. Tissue engineering for bone production- stem cells, gene therapy and scaffolds. Open Orthop J. 5:289–295.
- Lee GS, Park JH, Shin US, Kim HW. 2011. Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering. Acta Biomater. 7:3178–3186.
- Li AA, Shen F, Zhang T, Cirone P, Potter M, Chang PL. 2006. Enhancement of myoblast microencapsulation for gene therapy. J Biomed Mater Res B Appl Biomater. 77:296–306.
- Lim F, Sun AM. 1980. Microencapsulated islets as bioartificial endocrine pancreas. Science (New York, NY). 210:908–910.
- Maus U, Andereya S, Gravius S, Ohnsorge JA, Niedhart C, Siebert CH. 2008. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep. J Biomater Appl. 22:559–576.
- Mladenov KV, Kunkel P, Stuecker R. 2010. The use of recombinant human BMP-2 as a salvage procedure in the pediatric spine: a report on 3 cases. Eur Spine J. 19:S135–S139.
- Murakami N, Saito N, Takahashi J, Ota H, Horiuchi H, Nawata M, et al. 2003. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials. 24:2153–2159.
- Quarto N, Li S, Renda A, Longaker MT. 2012. Exogenous activation of BMP-2 signaling overcomes TGFbeta-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells. Stem Cells. 30:2709–2719.
- Santos E, Orive G, Calvo A, Catena R, Fernandez-Robredo P, Layana AG, et al. 2012. Optimization of 100 mum alginate-poly-L-lysine-alginate capsules for intravitreous administration. J Control Release. 158:443–450.
- Schmoekel HG, Weber FE, Schense JC, Gratz KW, Schawalder P, Hubbell JA. 2005. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng. 89:253–262.
- Shegarfi H, Reikeras O. 2009. Review article: bone transplantation and immune response. J Orthop Surg (Hong Kong). 17:206–211.
- Tai IT, Sun AM. 1993. Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J. 7:1061–1069.
- Wang CJ, Weng LH, Hsu SL, Sun YC, Yang YJ, Chan YS, Yang YL. 2010. pCMV-BMP-2-transfected cell-mediated gene therapy in anterior cruciate ligament reconstruction in rabbits. Arthroscopy. 26:968–976.
- Yao Y, Zhang F, Zhou R, Su K, Fan J, Wang DA. 2010. Effects of combinational adenoviral vector-mediated TGF beta 3 transgene and shRNA silencing type I collagen on articular chondrogenesis of synovium-derived mesenchymal stem cells. Biotechnol Bioeng. 106:818–828.
- Young BH, Peng H, Huard J. 2002. Muscle-based gene therapy and tissue engineering to improve bone healing. Clin Orthop Relat Res.S243–251.
- Zeng L, Yao Y, Wang DA, Chen X. 2014. Effect of microcavitary alginate hydrogel with different pore sizes on chondrocyte culture for cartilage tissue engineering. Mater Sci Eng C Mater Biol Appl. 34: 168–175.
- Zhang J, Neoh KG, Hu X, Kang ET, Wang W. 2013. Combined effects of direct current stimulation and immobilized BMP-2 for enhancement of osteogenesis. Biotechnol Bioeng. 110: 1466–1475.
- Zhang Y, Wang W, Zhou J, Yu W, Zhang X, Guo X, Ma X. 2007. Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells. Ann Biomed Eng. 35:605–614.
- Zhou H, Xu HH. 2011. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials. 32:7503–7513.